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Background: Ginsenosides, the major ingredients of Panax ginseng, have been studied for many decades
in Asian countries as a result of their wide range of pharmacological properties. The less polar ginse-
nosides, with one or two sugar residues, are not present in nature and are produced during
manufacturing processes by methods such as heating, steaming, acid hydrolysis, and enzyme reactions.
1H-NMR and 13C-NMR spectroscopic data for the identiﬁcation of the less polar ginsenosides are often
unavailable or incomplete.
Methods: We isolated 21 compounds, including 10 pairs of 20(S) and 20(R) less polar ginsenosides (1
e20), and an oleanane-type triterpene (21) from a processed ginseng preparation and obtained complete
1H-NMR and 13C-NMR spectroscopic data for the following compounds, referred to as compounds 1e21
for rapid identiﬁcation: 20(S)-ginsenosides Rh2 (1), 20(R)-Rh2 (2), 20(S)-Rg3 (3), 20(R)-Rg3 (4), 60-O-
acetyl-20(S)-Rh2 [20(S)-AcetylRh2] (5), 20(R)-AcetylRh2 (6), 25-hydroxy-20(S)-Rh2 (7), 25-hydroxy-
20(S)-Rh2 (8), 20(S)-Rh1 (9), 20(R)-Rh1 (10), 20(S)-Rg2 (11), 20(R)-Rg2 (12), 25-hydroxy-20(S)-Rh1 (13),
25-hydroxy-20(R)-Rh1 (14), 20(S)-AcetylRg2 (15), 20(R)-AcetylRg2 (16), Rh4 (17), Rg5 (18), Rk1 (19), 25-
hydroxy-Rh4 (20), and oleanolic acid 28-O-b-D-glucopyranoside (21).
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Ginsenosides, major components in Panax ginseng Meyer, are
mainly classiﬁed into two groups of the dammarane-type tri-
terpenes: protopanaxadiol (PPD) and protopanaxatriol (PPT) [1].
The substitution of sugar chains at C-3 or C-20 in PPD, or at C-3,
C-6, and C-20 in PPT gives rise to a wide range of ginsenosides
[2]. The PPD type typically includes the ginsenosides Rb1, Rb2,
Rc, and Rd, whereas the PPT type includes Re, Rf, Rg1, and Rg2,
which have three to ﬁve sugar moieties, in harvested ginseng.
During processing by steaming with heat and acidic solutions, or
in microbial reactions, these polar ginsenosides decrease and the
less polar ginsenosides, such as Rg2, Rg3, Rh1, and Rh2, increase
[3e5]. It has been suggested that they could be generated by the
elimination of sugar chains or by dehydroxylation [6]. These
reactions can also generate the irregular D20(21) and D20(22)
ginsenosides, such as Rg5, Rh3, Rh4, and Rk1, which are rarelyesearch Institute of Pharmaceutica
erms of the Creative Commons At
ribution, and reproduction in any
e Korean Society of Ginseng, Publfound in nature [7]. In particular, the 20(R)-ginsenosides,
including 20(R)-Rh2 and 20(R)-Rg3, are derived by selective
deglycosylation and dehydroxylation at C-20, followed by
biotransformation by reaction with a hydroxyl group [8,9]. The
acetylated ginsenosides are generated by decarboxylation from
the malonylated ginsenosides, including malonyl (Mal)-Rb1, Rb2,
Rc, Rd, and Re [10]. As the less polar ginsenosides can be easily
absorbed into blood vessels and act as the pharmacological
agents with potential as drug candidates, the mass production or
isolation of the less polar ginsenosides is of much interest in the
ginseng industry [5].
Recent improvements in chromatographic techniques have led
to the analysis and isolation of the stereoisomers of minor ginse-
nosides in ginseng preparations [11]. The structureeactivity re-
lationships between the diverse ginsenosides isolated by these
improved techniques has been studied in both cancer cells and
noncancer cells [12].l Sciences, Seoul National University, Seoul 151-742, Korea.
tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)
medium, provided the original work is properly cited.
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Fig. 1. Structures of compounds 1e21 isolated from the processed ginseng extract. Glu,
b-D-Glucose; AcetylGlu, b-D-60-O-Acetyl-glucose; Rha, a-L-Rhamnose.
H. Yang et al / Ginsenoside 1H-NMR and 13C-NMR data 195In this study, we isolated 21 minor ginsenosides from a pro-
cessed ginseng preparation and unequivocally determined their
structures by one-dimensional and two-dimensional NMR spec-
troscopy and compared these results with previously published
data. The NMR data obtained for these minor ginsenosides will be
useful in studying the structureeactivity relationships between
structural modiﬁcations such as the number of sugar groups, the
sugar linkage at C-6, the number of hydroxyl groups, and the ste-
reoisomers of 20(S) and 20(R), as well as in the identiﬁcation of
stereoisomers of ginsenosides.
2. Materials and methods
2.1. General procedure
Column chromatography (CC) was carried out using Kiesgel 60
silica gel (40e60 mm, 230e400 mesh, Merck, USA), YMC-GEL ODS-
A (5e150 mm, YMC), and Sephadex LH-20 (25e100mM, Pharmacia,
NJ, USA) columns. Thin-layer chromatography was carried out us-
ing Kiesgel 60 F254 coated normal silica gel and RP-18 F254 coated
reversed-phase (RP) silica gel columns. The 1H-NMR and 13C-NMR,
1H-1H COSY, HSQC, and HMBC spectra were recorded on a Bruker
AMX 500 or 600 spectrometer in pyridine-d5. The solvent signals
were used as internal standards. The high-performance liquid
chromatography (HPLC) system consisted of a G-321 pump (Gilson,
USA), a G-151 UV detector (Gilson), and a YMC-Pack Pro C18 column
(250 mm  10 mm i.d.; 5 mm); and all chromatograms were
monitored at 210 nm. HPLC-grade solvents (Fisher Scientiﬁc, USA)
were used in the MeOHeH2O or MeCNeH2O system.
2.2. Ginseng preparation
The processed ginseng preparation was gifted from Green-
crosshs (Sungnam, Korea). It was prepared using patented tech-
nology and a previously reported method [13]. Brieﬂy, the
harvested ginseng was repeatedly extracted with ethanol, followed
by reaction with an enzyme containing ginsenoside-b-glucosidase.
After acid hydrolysis of the residue, the reactant was puriﬁed with
HP-20 resin followed by washing out with distilled water and,
ﬁnally, 95% ethanol.
2.3. Isolation of ginsenosides from the processed ginseng
preparation
Powders of the processed ginseng extract (GE) (90 g) were each
subjected to normal silica CC (20  5 cm column) with a gradient
elution of solvents (CHCl3:MeOH ¼ 10:1, 7:1, 5:1, 3:1, 0:1; all 1-L
volumes) and 24 sub-fractions (GE1e24) were obtained. 20(S/R)-
AcetylRh2 (5, 6) (20 mg, Rt ¼ 14.1 min) were obtained from the GE-
5 (2.8 g) sub-fraction by RP silica gel CC (20  5 cm;
MeOH:H2O ¼ 9:1, 1 L), followed by preparative HPLC
(MeOH:H2O ¼ 65:35, 4 mL/min). Oleanolic acid 28-O-b-D-gluco-
pyranose (21) (200 mg) was isolated by recrystallization (100%
MeOH) from the sub-fraction separated from the GE-7 (6.5 g) sub-
fraction by RP silica gel CC (10  3 cm; MeOH:H2O ¼ 7:3, 2 L). Five
sub-fractions (GE8e10 AeE) were obtained from GE8e10 (12.1 g)
by RP silica gel CC (MeOH:H2O ¼ 8.5:1.5, 4 L). Rh4 (17) (5 mg,
Rt ¼ 19.1 min) was isolated from GE8e10 B, and 20(S)-Rh2 (1)
(300 mg, Rt ¼ 5.7 min) and 20(R)-Rh2 (2) (210 mg, Rt ¼ 6.1 min)
were isolated from GE8e10 C by preparative HPLC
(MeCN:H2O ¼ 55:45, 13 mL/min). The mixtures of 25-hydroxy-Rh4
(20) (35mg, Rt¼ 11.1min), 20S/R-Rh1 (9,10) (90mg, Rt¼ 13.2min),
25-hydroxy-20(S)-Rh2 (7) (28 mg, Rt ¼ 23.1 min), and 25-hydroxy-
20(R)-Rh2 (8) (100 mg, Rt ¼ 23.3 min) were prepared from GE12e
14 (8.2 g) and were isolated by RP silica gel CC (10  3 cm;
Table 1
1H-NMR Spectroscopic Data for Compounds 1e8 in Pyridine-d5






dH (J in Hz)
1a 1.49 (1H, m) 1.49 (1H, m) 1.46 (1H, m) 1.47 (1H, m) 1.58 (1H, m) 1.49 (1H, m) 1.49 (1H, m)
1b 0.79 (1H, m) 0.79 (1H, m) 0.72 (1H, m) 0.72 (1H, m) 0.88 (1H, m) 0.75 (1H, m) 0.75 (1H, m)
2a 2.19 (1H, m) 2.20 (1H, m) 2.16 (1H, m) 2.17 (1H, m) 2.12 (1H, m) 2.20 (1H, m) 2.18 (1H, m)
2b 1.78 (1H, m) 1.79 (1H, m) 1.79 (1H, m) 1.81 (1H, m) 1.78 (1H, m) 1.38 (1H, m) 1.36 (1H, m)
3 3.35 (1H, dd,
J ¼ 4.6, 11.9)
3.36 (1H, dd,
J ¼ 3.7, 11.5)
3.26 (1H, dd,
J ¼ 11.75, 4.35)
3.26 (1H, dd,
J ¼ 11.75, 4.35)
3.24 (1H, m) 3.36 (1H, dd,
J ¼ 4.4, 11.7)
3.35 (1H, dd,
J ¼ 4.4, 11.7)
5 0.72
(1H, d, J ¼ 11.9)
0.73
(1H, d, J ¼ 11.5)
0.65
(1H, d, J ¼ 11.4)
0.66
(1H, d, J ¼ 11.5)
0.71 (1H, m) 0.73 (1H, m) 0.71 (1H, m)




6b 1.35 (1H, m) 1.40 (1H, m)
7a 1.47 (1H, m) 1.49 (1H, m) 1.42 (1H, m) 1.41 (1H, m) 1.45 (1H, m) 1.47 (1H, m) 1.48 (1H, m)
7b 1.21 (1H, m) 1.23 (1H, m) 1.19 (1H, m) 1.21 (1H, m) 1.20 (1H, m) 1.22 (1H, m) 1.22 (1H, m)
9 1.40 (1H, m) 1.42 (1H, m) 1.37 (1H, m) 1.37 (1H, m) 1.41 (1H, m) 1.41 (1H, m) 1.41 (1H, m)
11a 1.58 (1H, m) 1.58 (1H, m) 2.02 (1H, m) 2.00 (1H, m) 1.52 (1H, m) 2.05 (1H, m) 2.03 (1H, m)
11b 1.11 (1H, m) 1.13 (1H, m) 1.55 (1H, m) 1.55 (1H, m) 1.02 (1H, m) 1.54 (1H, m) 1.52 (1H, m)
12 3.89 (1H, m) 3.91 (1H, m) 3.90 (1H, m) 3.91 (1H, m) 3.82 (1H, m) 3.90 (1H, m) 3.90 (1H, m)
13 2.01 (1H, m) 2.00 (1H, m) 2.00 (1H, m) 1.97 (1H, m) 1.94 (1H, m) 2.06 (1H, m) 2.00 (1H, m)
15a 2.01 (1H, m) 2.11 (1H, m) 1.50 (1H, m) 1.56 (1H, m) 1.96 (1H, m) 1.58 (1H, m) 1.57 (1H, m)
15b 1.49 (1H, m) 1.51 (1H, m) 1.05 (1H, m) 1.04 (1H, m) 1.42 (1H, m) 1.02 (1H, m) 1.02 (1H, m)
16a 1.88 (1H, m) 1.91 (1H, m) 1.87 (1H, m) 1.93 (1H, m) 1.84 (1H, m) 1.92 (1H, m) 1.91 (1H, m)
16b 1.39 (1H, m) 1.35 (1H, m) 1.38 (1H, m) 1.35 (1H, m) 1.44 (1H, m) 1.81 (1H, m) 1.80 (1H, m)
17 2.35 (1H, m) 2.38 (1H, m) 2.33 (1H, m) 2.38 (1H, m) 2.26 (1H, m) 2.30 (1H, m) 2.34 (1H, m) 2.40 (1H, m)
18 0.77 (3H, s) 0.80 (3H, s) 0.94 (3H, s) 0.99 (3H, s) 0.94 (3H, s) 0.91 (3H, s) 0.80 (3H, s) 0.81 (3H, s)
19 0.94 (3H, s) 1.00 (3H, s) 0.77 (3H, s) 0.80 (3H, s) 0.78 (3H, s) 1.01 (3H, s) 1.00 (3H, s)
21 1.40 (3H, s) 1.38 (3H, s) 1.40 (3H, s) 1.37 (3H, s) 1.32 (3H, s) 1.41 (3H, s) 1.38 (3H, s)
22a 2.01 (1H, m) 1.70 (2H, m) 2.01 (1H, m) 1.71 (2H, m) 1.90 (1H, m) 1.62 (2H, m) 2.00 (1H, m) 1.71 (2H, m)
22b 1.68 (1H, m) 1.68 (1H, m) 1.58 (1H, m) 1.63 (1H, m)
23a 2.57 (1H, m) 2.52 (1H, m) 2.58 (1H, m) 2.52 (1H, m) 2.46 (1H, m) 2.48 (1H, m) 2.16 (1H, m) 2.10 (2H, m)
23b 2.29 (1H, m) 2.45 (1H, m) 2.26 (1H, m) 2.47 (1H, m) 2.16 (1H, m) 2.42 (1H, m) 1.82 (1H, m) 1.98 (1H, m)
24 5.29 (1H, t-like) 5.30 (1H, t-like) 5.28 (1H, t, J ¼ 6.95) 5.30 (1H, t-like) 5.24 (1H, m) 5.25 (1H, m) 1.71 (2H, m) 1.71 (2H, m)
26 1.63 (3H, s) 1.68 (3H, s) 1.60 (3H, s) 1.68 (3H, s) 1.62 (3H, s) 1.37 (3H, s) 1.40 (3H, s)
27 1.60 (3H, s) 1.63 (3H, s) 1.60 (3H, s) 1.64 (3H, s) 1.55 (3H, s) 1.38 (3H, s) 1.40 (3H, s)
28 1.30 (3H, s) 1.30 (3H, s) 1.27 (3H, s) 1.27 (3H, s) 1.20 (3H, s) 1.30 (3H, s) 1.30 (3H, s)
29 0.97 (3H, s) 0.98 (3H, s) 1.08 (3H, s) 1.09 (3H, s) 0.88 (3H, s) 0.98 (3H, s) 0.98 (3H, s)
30 0.94 (3H, s) 0.98 (3H, s) 0.92 (3H, s) 0.96 (3H, s) 0.96 (3H, s) 0.94 (3H, s) 0.94 (3H, s)
3-O-b-D-Glucopyranosyl
10 4.92 (1H, d, J ¼ 7.8) 4.92 (1H, d, J ¼ 7.60) 4.90 (1H, d, J ¼ 7.55) 4.91 (1H, d,
J ¼ 7.6)




20 4.02 (1H, m) 4.02 (1H, m) 4.23 (1H, m) 4.22 (1H, m) 3.92 (1H, m) 4.02 (1H, m) 4.01 (1H, m)
30 4.23 (1H, t, J ¼ 8.7) 4.22 (1H, m) 4.21 (1H, m) 4.20 (1H, m) 4.06 (1H, m) 4.25 (1H, m) 4.22 (1H, t,
J ¼ 8.8)
40 4.18 (1H, t, J ¼ 8.7) 4.18 (1H, m) 4.11 (1H, m) 4.13 (1H, m) 3.88 (1H, m) 4.20 (1H, m) 4.18 (1H, t,
J ¼ 8.8)
50 3.90 (1H, m) 3.98 (1H, m) 3.88 (1H, m) 3.89 (1H, m) 3.87 (1H, m) 3.99 (1H, m) 3.98 (1H, m)
60a 4.56 (1H, d, J ¼ 11.9) 4.57 (1H, d, J ¼ 11.9) 4.53 (1H, m) 4.54 (1H, m) 4.79 (1H, m) 4.57 (1H, dd,
J ¼ 2.2, 11.7)
4.56 (1H, dd,
J ¼ 1.9, 11.7)
60b 3.67 (1H, dd,
J ¼ 5.5, 11.9)
4.37 (1H, dd,
J ¼ 5.5, 11.9)
4.33 (1H, m) 4.32 (1H, m) 4.67 (1H, dd,
J ¼ 6.42, 11.88)
4.37 (1H, dd,
J ¼ 5.4, 11.7)
4.37 (1H, dd,
J ¼ 5.4, 11.7)
20-O-b-D-Glucopyranosyl
10 0 5.35 (1H, d, J ¼ 7.65) 5.36 (1H, d,
J ¼ 7.65)
20 0 4.10 (1H, m) 4.12 (1H, m)
30 0 4.29 (1H, m) 4.28 (1H, m)
40 0 4.32 (1H, m) 4.31 (1H, m)
50 0 3.91 (1H, m) 3.93 (1H, m)
60 0a 4.46 (1H, m) 4.46 (1H, m)
60 0b 4.45 (1H, m) 4.45 (1H, m)
COCH3 1.93 (3H, s)
1) 1H-NMR data measured at 600 MHz
2) 1H-NMR data measured at 500 MHz
3) 20(S/R)-AcetylRh2; 60-O-acetyl-20(S/R)-Rh2
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Table 2
13C-NMR Spectroscopic Data for Compounds 1e8 in Pyridine-d5







1 39.1 t 39.1 t 39.1 t 39.1 t 38.9 t 39.1 t 39.1 t
2 26.7 t 26.6 t 26.7 t 26.6 t 26.6 t 26.7 t 26.7 t
3 88.7 d 88.7 d 88.9 d 88.9 d 89.0 d 88.8 d 88.7 d
4 39.6 s 39.6 s 39.6 s 39.6 s 39.4 s 39.7 s 39.6 s
5 56.3 d 56.3 d 56.3 d 56.3 d 56.2 d 56.1 d 56.4 d 56.3 d
6 18.4 t 18.4 t 18.4 t 18.4 t 18.2 t 18.4 t 18.4 t
7 35.1 t 35.1 t 35.1 t 35.1 t 34.9 t 35.2 t 35.1 t
8 40.0 s 40.0 s 39.9 s 40.0 s 39.8 s 40.0 s 40.0 s
9 50.3 d 50.3 d 50.3 d 50.3 d 50.2 d 50.4 d 50.3 d
10 36.9 s 36.9 s 36.8 s 36.9 s 36.8 s 37.0 s 36.9 s
11 31.3 t 31.4 t 31.3 t 31.4 t 31.1 t 31.2 t 32.1 t 32.1 t
12 70.9 d 70.8 d 70.9 d 70.8 d 70.7 d 70.6 d 71.0 d 70.8 d
13 48.5 d 49.2 d 48.5 d 49.2 d 48.9 d 48.2 d 48.6 d 49.2 d
14 51.7 s 51.7 s 51.6 s 51.7 s 51.5 s 51.7 s 51.7 s
15 32.0 t 32.1 t 32.0 t 32.1 t 31.7 t 31.8 t 31.4 t 31.4 t
16 26.8 t 26.7 t 26.8 t 26.7 t 26.4 t 27.2 t 26.6 t
17 54.7 d 50.6 d 54.7 d 50.6 d 54.5 d 50.3 d 54.7 d 50.7 d
18 16.3 q 16.3 q 15.8 q 15.8 q 15.6 q 16.8 q 16.7 q
19 15.8 q 15.8 q 16.3 q 16.3 q 16.1 q 15.8 q 15.8 q
20 72.9 s 72.9 s 72.9 s 72.9 s 72.8 s 73.3 s 73.3 s
21 27.0 q 22.7 q 27.0 q 22.7 q 26.7 q 22.4 q 26.9 q 22.8 q
22 35.8 t 43.2 t 35.8 t 43.2 t 35.6 t 42.9 t 36.5 t 44.0 t
23 22.9 t 22.6 t 23.0 t 22.5 t 22.3 t 22.7 t 19.1 t 18.7 t
24 126.3 d 126 d 126.2 d 126.0 d 126.0 d 125.8 d 45.7 t 45.5 t
25 130.7 s 130.7 s 130.7 s 130.7 s 130.5 s 69.6 s 69.7 s
26 25.8 q 25.8 q 25.7 q 25.8 q 25.7 q 25.6 q 30.2 q 30.1 q
27 17.6 q 17.7 q 17.0 q 17.2 q 17.1 q 16.8 q 29.9 q 29.9 q
28 28.1 q 28.1 q 28.1 q 28.1 q 27.9 q 28.1 q 28.1 q
29 16.7 q 16.7 q 16.5 q 16.5 q 16.5 q 16.4 q 16.3 q
30 17.0 q 17.3 q 17.6 q 17.6 q 17.5 q 17.0 q 17.3 q
3-O-b-D-Glucopyranosyl
10 106.9 d 106.9 d 105.0 d 105.1 d 106.6 d 106.9 d 106.9 d
20 75.7 d 75.7 d 83.4 d 83.4 d 74.5 d 75.8 d 75.7 d
30 78.7 d 78.7 d 77.9 d 77.9 d 78.1 d 78.7 d 78.7 d
40 71.8 d 71.8 d 71.6 d 71.6 d 71.3 d 71.9 d 71.8 d
50 78.3 d 78.3 d 78.2 d 78.2 d 75.1 d 78.3 d 78.3 d
60 63.0 t 63.0 t 62.8 t 62.8 t 64.4 t 63.1 t 63.0 t
20-O-b-D-Glucopyranosyl
10 0 106.0 d 106.0 d
20 0 77.1 d 77.1 d
30 0 78.3 d 78.3 d
40 0 71.6 d 71.6 d
50 0 78.0 d 78.1 d
60 0 62.7 t 62.7 t
COCH3 170.5 s
COCH3 20.6 q
Multiplicity of 13C-NMR data was determined by DEPT experiments
1) 13C-NMR data measured at 150 MHz
2) 13C-NMR data measured at 125 MHz
3) 20(S/R)-AcetylRh2; 60-O-acetyl-20(S/R)-Rh2
H. Yang et al / Ginsenoside 1H-NMR and 13C-NMR data 197MeOH:H2O ¼ 7:3, 4 L) followed by preparative HPLC
(MeCN:H2O ¼ 50:50, 70:30, 13 mL/min). GE15e18 (10.1 g) were
subjected to RP silica gel CC (MeOH:H2O¼ 6:4, 4 L) to give ﬁve sub-
fractions (GE15e18 AeE). 20S-AcetylRg2 (15) (15mg, Rt¼ 24.7min)
and 20R-AcetylRg2 (16) (8 mg, Rt ¼ 25.1 min) were isolated from
GE15e18 B. Rk1 (19) (25 mg, Rt ¼ 19.9 min) and Rg5 (18) (31 mg,
Rt¼ 20.3 min) were obtained from GE15e18 D by preparative HPLC
(MeOH:H2O ¼ 7:3, 10 mL/min), respectively. 20(S/R)-Rg2 (11, 12)
(50 mg), 20(S)-Rg3 (3) (400 mg), and 20(R)-Rg3 (4) (400 mg) were
obtained from GE19e20 (8.1 g) sub-fractions by RP silica gel CC
(10  3 cm) with a mixture of MeOH:H2O (3:1, 5 L). 20(S)-Rg2 (11)
(10 mg, Rt ¼ 13.1 min) and 20(R)-Rg2 (12) (15 mg, Rt ¼ 13.4 min)
were puriﬁed using preparative HPLC (MeCN:H2O ¼ 35:65, 10 mL/
min). GE21e22 (3.1 g) sub-fractions were further isolated to give
the mixture of 25-hydroxy-20(S/R)-Rh1 (13, 14) (30 mg).3. Results and discussion
The structures of compounds 1e21 were unequivocally deter-
mined by comparing the one-dimensional and two-dimensional
NMR spectrometry and mass spectrometry data with previously
published values. These were: 20(S)-ginsenosides Rh2 (1) [14],
20(R)-Rh2 (2) [15], 20(S)-Rg3 (3) [16], 20(R)-Rg3 (4) [16], 60-O-
acetyl-20(S)-Rh2 (20(S)-AcetylRh2) (5) [16], 20(R)-AcetylRh2 (6)
and 25-hydroxy-20(S)-Rh2 (7) [13], 25-hydroxy-20(R)-Rh2 (8) [13],
20(S)-Rh1 (9) [17], 20(R)-Rh1 (10) [17], 20(S)-Rg2 (11) [17], 20(R)-
Rg2 (12) [18], 25-hydroxy-20(S)-Rh1 (13) [19], 25-hydroxy-20(R)-
Rh1 (14) [19], 20(S)-AcetylRg2 (15) [20], 20(R)-AcetylRg2 (16) [20],
Rk1 (17) [21], Rh4 (18) [17], 25-hydroxy-Rh4 (19) [18], Rg5 (20) [21],
and oleanolic acid 28-O-b-D-glucopyranoside (21) [22] (Fig. 1). Of
these compounds, compound 6 had not been reported previously.
Table 3
1H-NMR Spectroscopic Data for Compounds 9e16 in Pyridine-d5
No. 20(S)-Rh11) (9) 20(R)-Rh11) (10) 20(S)-Rg21) (11) 20(R)-Rg22) (12) 25-Hydroxy-20(S/R)-Rh1 1) (13 and 14) 20(S)-Acetyl-Rg21),3) (15) 20(R)-Acetyl-Rg21),4) (16)
dH (J in Hz)
1a 1.66 (1H, m) 1.69 (1H, m) 1.61 (1H, m) 1.61 (1H, m) 1.67 (1H, m) 1.65 (1H, m) 1.64 (1H, m)
1b 1.02 (1H, m) 1.01 (1H, m) 0.92 (1H, m) 0.92 (1H, m) 1.02 (1H, m) 0.98 (1H, m) 0.97 (1H, m)
2a 1.89 (1H, m) 1.90 (1H, m) 1.83 (1H, m) 1.82 (1H, m) 1.89 (1H, m) 1.82 (1H, m) 1.82 (1H, m)
2b 1.80 (1H, m) 1.80 (1H, m) 1.76 (1H, m) 1.76 (1H, m) 1.82 (1H, m) 1.76 (1H, m) 1.76 (1H, m)
3 3.50 (1H, m) 3.50 (1H, br d) 3.43 (1H, m) 3.35 (1H, br s) 3.50 (1H, m) 3.46 (1H, m) 3.46 (1H, dd, J ¼ 4.1, 11.2)
5 1.40 (1H, m) 1.42 (1H, d, J ¼ 10.5) 1.37 (1H, m) 1.39 (1H, m) 1.42 (1H, m) 1.37 (1H, m) 1.39 (1H, m)
6 4.40 (1H, td, J ¼ 2.8, 10.5 ) 4.43 (1H, td, J ¼ 2.9, 10.5 ) 4.64 (1H, m) 4.68 (1H, m) 4.42 (1H, m) 4.75 (1H, s) 4.70 (1H, td, J ¼ 3.3, 10.6)
7a 2.50 (1H, m) 2.51 (1H, m) 2.22 (1H, m) 2.23 (1H, m) 2.51 (1H, m) 2.14 (1H, m) 2.15 (1H, m)
7b 1.91 (1H, m) 1.93 (1H, m) 1.95 (1H, m) 1.96 (1H, m) 1.93 (1H, m) 1.97 (1H, m) 1.98 (1H, m)
9 1.53 (1H, m) 1.57 (1H, m) 1.51 (1H, m) 1.52 (1H, m) 1.58 (1H, m) 1.55 (1H, s) 1.56 (1H, s)
11a 2.11 (1H, m) 2.13 (1H, m) 2.04 (1H, m) 2.09 (1H, m) 2.13 (1H, m) 2.14 (1H, m) 2.15 (1H, m)
11b 1.56 (1H, m) 1.52 (1H, m) 1.51 (1H, m) 1.54 (1H, m) 1.56 (1H, m) 1.56 (1H, m) 1.57 (1H, m)
12 3.88 (1H, m) 3.91 (1H, m) 3.89 (1H, m) 3.90 (1H, m) 3.89 (1H, m) 3.93 (1H, m) 3.95 (1H, m)
13 2.01 (1H, m) 2.00 (1H, m) 1.97 (1H, m) 1.96 (1H, m) 2.02 (1H, m) 2.04 (1H, m) 2.01 (1H, m)
15a 1.59 (1H, m) 1.59 (1H, m) 1.51 (1H, m) 1.50 (1H, m) 1.63 (1H, m) 1.62 (1H, m) 1.62 (1H, m)
15b 1.07 (1H, m) 1.11 (1H, m) 0.83 (1H, m) 0.91 (1H, m) 1.10 (1H, m) 0.98 (1H, m) 1.02 (1H, m)
16a 1.76 (1H, m) 1.80 (1H, m) 1.73 (1H, m) 1.82 (1H, m) 1.32 (2H, m) 1.82 (1H, m) 1.88 (1H, m)
16b 1.30 (1H, m) 1.28 (1H, m) 1.28 (1H, m) 1.22 (1H, m) 1.38 (1H, m) 1.30 (1H, m)
17 2.26 (1H, m) 2.32 (1H, m) 2.25 (1H, m) 2.34 (1H, m) 2.28 (1H, m) 2.35 (1H, m) 2.31 (1H, m) 2.37 (1H, m)
18 1.16 (3H, s) 1.22 (3H, s) 1.18 (3H, s) 1.22 (3H, s) 1.03 (3H, s) 1.22 (3H, s) 1.25 (3H, s)
19 1.00 (3H, s) 1.04 (3H, s) 0.93 (3H, s) 0.96 (3H, s) 1.25 (3H, s) 0.99 (3H, s) 1.02 (3H, s)
21 1.37 (3H, s) 1.37 (3H, s) 1.38 (3H, s) 1.36 (3H, s) 1.38 (3H, s) 1.35 (3H, m) 1.35 (3H, s)
22a 2.01 (1H, m) 1.68 (2H, m) 1.98 (1H, m) 2.01 (1H, m) 2.00 (1H, m) 1.67 (2H, m) 2.04 (1H, m) 1.68 (2H, m)
22b 1.66 (1H, m) 1.62 (1H, m) 1.68 (1H, m) 1.63 (1H, m) 1.67 (1H, m)
23a 2.56 (1H, m) 2.48 (1H, m) 2.58 (1H, m) 2.57 (1H, m) 2.13 (1H, m) 2.02-1.99 (2H, m) 2.57 (1H, m) 2.49 (1H, m)
23b 2.25 (1H, m) 2.41 (1H, m) 2.23 (1H, m) 2.29 (1H, m) 1.86 (1H, m) 2.25 (1H, m) 2.41 (1H, m)
24 5.30 (1H, t-like) 5.28 (1H, t-like) 5.31 (1H, t-like) 5.29 (1H, t-like) 1.70 (2H, t-like) 5.29 (1H, t-like) 5.28 (1H, t-like)
26 1.63 (3H, s) 1.67 (3H, s) 1.63 (3H, s) 1.67 (3H, s) 1.38 (3H, s) 1.62 (3H, s) 1.68 (3H, m)
27 1.60 (3H, s) 1.61 (3H, s) 1.60 (3H, s) 1.62 (3H, s) 1.40 (3H, s) 1.59 (3H, s) 1.60 (3H, s)
28 2.05 (3H, s) 2.06 (3H, s) 2.06 (3H, s) 2.09 (3H, s) 2.05 (3H, s) 2.05 (3H, m) 2.03 (3H, m)
29 1.57 (3H, s) 1.59 (3H, s) 1.31 (3H, s) 1.34 (3H, s) 1.58 (3H, s) 1.29 (3H, s) 1.28 (3H, s)
30 0.79 (3H, s) 0.84 (3H, s) 0.91 (3H, s) 0.95 (3H, s) 0.82 (3H, s) 0.97 (3H, s) 1.00 (3H, s)
6-O-b-D-glucopyranosyl
10 5.00 (1H, m) 5.03 (1H, m) 5.23 (1H, d, J ¼ 6.9) 5.26 (1H, m) 5.02 (1H, m) 5.22 (1H, d, J ¼ 7.0) 5.22 (1H, d, J ¼ 7.0)
20 4.08 (1H, m) 4.09 (1H, m) 4.32 (1H, m) 4.32 (1H, m) 4.07 (1H, m) 4.33 (1H, m) 4.32 (1H, m)
30 4.23 (1H, m) 4.25 (1H, m) 4.33 (1H, m) 4.36 (1H, m) 4.23 (1H, m) 4.29 (1H, m) 4.29 (1H, m)
40 4.19 (1H, m) 4.20 (1H, m) 4.19 (1H, m) 4.19 (1H, m) 4.07 (1H, m) 3.92 (1H, m) 3.94 (1H, m)
50 3.92 (1H, m) 3.95 (1H, m) 3.93 (1H, m) 3.95 (1H, m) 3.94 (1H, m) 4.01 (1H, t-like) 4.03 (1H, t-like, J ¼ 8.2)
60a 4.51 (1H, m) 4.52 (1H, dd, J ¼ 1.9, 11.4) 4.49 (1H, m) 4.50 (1H, m) 4.51 (1H, m) 5.00 (1H, m) 4.90 (1H, m)
60b 4.34 (1H, m) 4.35 (1H, dd, J ¼ 5.3, 11.4) 4.36 (1H, m) 4.37 (1H, m) 4.34 (1H, m) 4.61 (1H, m) 4.63 (1H, m)
20-O-a-L-rhamnopyranosyl
10 6.47 (1H, br s) 6.47 (1H, s) 6.47 (1H, s) 6.47 (1H, s)
20 0 4.75 (1H, m) 4.78 (1H, m) 4.68 (1H, dt, J ¼ 3.2, 10.6) 4.75 (1H, m)
30 0 4.63 (1H, m) 4.66 (1H, m) 4.64 (1H, m) 4.64 (1H, m)
40 0 4.30 (1H, m) 4.31 (1H, m) 4.34 (1H, m) 4.33 (1H, m)
50 0 4.92 (1H, m) 4.94 (1H, m) 4.98 (1H, m) 4.80 (1H, m)
60 0 1.76 (3H, d, J ¼ 6.2) 1.78 (3H, br s) 1.76 (3H, d, J ¼ 6.2) 1.77 (3H, d, J ¼ 6.1)
COCH3 2.04 (3H, s) 2.08 (3H, s)
1) 1H-NMR data measured at 500 MHz












13C-NMR Spectroscopic Data for Compounds 9e16 in Pyridine-d5
No. 20(S)-Rh11) (9) 20(R)-Rh11) (10) 20(S)-Rg21) (11) 20(R)-Rg22) (12) 25-Hydroxy-20(S/R)-Rh11)
(13 and 14)




39.3 t 39.5 t 39.6 t 39.6 t 39.5 t 39.5 t
2
27.8 t
27.9 t 27.7 t 27.7 t 27.9 t 27.6 t 27.6 t
3
78.5 d
78.5 d 78.3 d 78.3 d 78.5 d 78.2 d 78.1 d
4
40.3 s
40.3 s 41.1 s 39.9 s 40.3 s 39.8 s 39.8 s
5
61.4 d
61.4 d 60.7 d 60.8 d 61.4 d 60.5 d 60.5 d
6
80.0 d
80.0 d 74.2 d 74.3 d 80.0 d 72.2 d 73.3 d
7
45.2 t
45.1 t 46.0 t 46.0 t 45.2 t 45.1 t 46.1 t 46.1 t
8
41.0 s
41.1 s 41.1 s 41.1 s 41.0 s 39.2 s 39.2 s
9
50.1 d
50.1 d 49.7 d 49.7 d 50.2 d 49.6 d 49.6 d
10
39.6 s
39.6 s 39.9 s 39.9 s 39.3 s 41.1 s 41.1 s
11
32.0 t
32.2 t 32.0 t 32.1 t 32.1 t 32.0 t 32.0 t
12
71.0 d
70.9 d 71.0 d 70.9 d 71.0 d 70.9 d 70.8 d
13
48.2 d
48.8 d 48.1 d 48.8 d 48.2 d 48.9 d 48.2 d 48.8 d
14
51.6 s
51.7 s 51.6 s 51.7 s 51.6 s 51.6 s 51.6 s
15
31.2 t
31.3 t 31.2 t 31.3 t 31.3 t 31.2 t 31.3 t
16
26.7 t
26.6 t 26.8 t 26.6 t 26.8 t 26.7 t 26.5 t
17
54.7 d
50.5 d 54.6 d 50.5 d 54.6 d 50.7 d 54.7 d 50.4 d
18
17.3 q
17.3 q 17.6 q 17.6 q 17.6 q 17.0 q 17.1 q
19
17.6 q
17.6 q 17.5 q 17.5 q 17.3 q 17.5 q 17.4 q
20
72.9 s
73.0 s 72.9 s 72.9 s 73.3 s 72.9 s 72.9 s
21
26.9 q
22.7 q 27.0 q 22.7 q 27.1 q 22.7 q 26.9 q 22.6 q
22
35.8 t
43.2 t 35.7 t 43.2 t 36.4 t 43.9 t 35.8 t 43.1 t
23
22.9 t
22.5 t 22.9 t 22.5 t 19.1 t 18.6 t 22.9 t 22.5 t
24
126.2 d
126.0 d 126.3 d 126.0 d 45.7 t 126.2 d 125.9 d
25
130.7 s
130.7 s 130.7 s 130.7 s 69.7 s 130.7 s 130.7 s
26
25.7 q
25.8 q 25.8 q 25.8 q 30.1 q 25.7 q 25.7 q
27
17.6 q
17.6 q 17.6 q 17.6 q 17.6 q 17.6 q 17.6 q
28
31.6 q
31.7 q 32.1 q 32.1 q 31.7 q 31.9 q 32.0 q
29
16.3 q
16.3 q 16.8 q 17.2 q 16.8 q 17.4 q 17.5 q
30
16.7 q




106.0 d 101.9 d 101.9 d 105.9 d 101.2 d 101.2 d
20
75.4 d
75.4 d 79.4 d 79.4 d 75.4 d 78.2 d 78.2 d
30
79.6 d
79.6 d 78.5 d 78.5 d 79.6 d 79.0 d 79.0 d
40
71.8 d
71.8 d 72.4 d 72.4 d 71.8 d 72.3 d 72.3 d
50
78.1 d
78.1 d 78.3 d 78.3 d 78.1 d 75.3 d 75.3 d
(continued on next page)
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Table 4 (continued )
No. 20(S)-Rh11) (9) 20(R)-Rh11) (10) 20(S)-Rg21) (11) 20(R)-Rg22) (12) 25-Hydroxy-20(S/R)-Rh11)
(13 and 14)
20(S)-Acetyl-Rg21),3) (15) 20(R)-Acetyl-Rg21),4) (16)
60a
63.0 t
63.0 t 63.0 t 63.1 t 64.8 t 64.8 t
20-O-a-L-Rhamnopyranosyl
10 101.7 d 101.7 d 102.0 d 102.0 d
20 0 72.2 d 72.2 d 73.3 d 72.2 d
30 0 72.5 d 72.6 d 72.2 d 72.2 d
40 0 74.1 d 74.1 d 74.0 d 74.0 d
50 0 69.4 d 69.4 d 69.3 d 69.3 d
60 0 18.7 q 18.7 q 18.6 q 18.6 q
COCH3 170.7 s 170.7 s
COCH3 20.8 q 20.8 q
Multiplicity of 13C-NMR data was determined by DEPT experiments
1) 13C-NMR data measured at 125 MHz




1H-NMR Spectroscopic Data for Compounds 17e21 in Pyridine-d5
No. Rk1 (17) Rh4 (18) 25-Hydroxy-Rh4 (19) Rg5 (20) Oleanolic acid 28-O-b-D-glu (21)
dH (J in Hz)
1a 1.49 (1H, m) 1.67 (1H, m) 1.68 (1H, m) 1.47 (1H, m) 1.50 (1H, m)
1b 0.74 (1H, m) 1.01 (1H, m) 1.03 (1H, m) 0.75 (1H, m) 0.97 (1H,m)
2a 2.18 (1H, m) 1.85 (1H, m) 1.88 (1H, m) 2.18 (1H, m) 1.80 (2H, m)
2b 1.80 (1H, m) 1.80 (1H, m) 1.82 (1H, m) 1.78 (1H, m)
3 3.27 (1H, dd, J ¼ 4.3, 11.7) 3.49 (1H, dd, J ¼ 4.7, 11.6) 3.50 (1H, dd, J ¼ 11.6, 4.6) 3.27 (1H, dd, J ¼ 4.3, 11.6) 3.42 (1H, dd, J ¼ 5.2, 10.8)
5 0.67 (1H, d, J ¼ 11.2) 1.40 (1H, m) 1.41 (1H, m) 0.67 (1H, d, J ¼ 11.1) 0.83 (1H, m)
6a 1.47 (1H, m) 4.40 (1H, td, J ¼ 3.2, 10.3) 4.41 (1H, td, J ¼ 10.6, 2.8) 1.51 (1H, m) 1.51 (1H, m)
6b 1.36 (1H, m) 1.36 (1H, m) 1.34 (1H, m)
7a 1.47 (1H, m) 2.49 (1H, m) 2.51 (1H, dd, J ¼ 12.7, 2.8) 1.43 (1H, m) 1.52 (1H, m)
7b 1.24 (1H, m) 1.92 (1H, m) 1.93 (1H, m) 1.21 (1H, m) 1.40 (1H, m)
9 2.80 (1H, m) 1.53 (1H, m) 1.55 (1H, m) 1.38 (1H, m) 1.64 (1H, m)
11a 1.91 (1H, m) 1.95 (1H, m) 1.56 (1H, m) 1.91 (1H, m) 2.08 (2H, m)
11b 1.40 (1H, m) 1.41 (1H, m) 1.46 (1H, m) 1.41 (1H, m) 5.44 (1H, m)
12 3.89 (1H, m) 3.88 (1H, m) 3.88 (1H, m) 3.90 (1H, m)
13 2.06 (1H, m) 2.71 (1H, m) 1.97 (1H, m) 2.77 (1H, m)
15a 1.45 (1H, m) 1.52 (1H, m) 1.71 (1H, m) 1.64 (1H, m) 2.35 (1H, m)
15b 1.06 (1H, m) 1.11 (1H, m) 1.18 (1H, m) 1.09 (1H, m) 1.16 (1H, m)
16a 2.06 (1H, m) 1.45 (2H, m) 1.46 (2H, m) 1.98 (1H, m) 2.36 (1H, m)
16b 1.57 (1H, m) 1.96 (1H, m) 2.72 (1H, m) 1.52 (1H, m) 1.92 (1H, m)
17 1.40 (1H, m) 1.20 (3H, s) 0.81 (3H, s) 1.98 (1H, m)
18 1.01 (3H, s) 1.01 (3H, s) 1.02 (3H, s) 1.01 (3H, s) 3.19 (1H, dd, J ¼ 2.8, 10.8)
19a 0.80 (3H, s) 0.81 (3H, s) 1.74 (1H, m)
19b 1.27 (1H, m)
21a 5.14 (2H, s) 1.77 (3H, s) 1.79 (3H, s) 1.81 (3H, s) 1.33 (1H, m)
21b 1.05 (1H, m)
22a 2.48 (1H, m) 5.43 (1H, t, J ¼ 7.0) 5.55 (1H, t, J ¼ 6.7) 5.50 (1H, t, J ¼ 6.6) 1.83 (1H, m)
22b 2.38 (1H, m) 1.74 (1H, m)
23 2.32 (1H, m) 2.72 (2H, m) 2.33 (2H, m) 2.77 (2H, m) 1.22 (3H, s)
24 5.28 (1H, m) 5.18 (1H, m) 1.71 (2H, m) 5.22 (1H, t, J ¼ 7.2) 1.01 (3H, s)
25 0.87 (3H, s)
26 1.66 (3H, s) 1.59 (3H, s) 1.33 (3H, s) 1.62 (3H, s) 1.12 (3H, s)
27 1.59 (3H, s) 1.56 (3H, s) 1.33 (3H, s) 1.58 (3H, s) 1.21 (3H, s)
28 1.27 (3H, s) 2.02 (3H, s) 2.04 (3H, s) 1.28 (3H, s)
29 1.09 (3H, s) 1.55 (3H, s) 1.58 (3H, s) 1.10 (3H, s) 0.91 (3H, s)
30 0.95 (3H, s) 0.80 (3H, s) 1.22 (3H, s) 0.95 (3H, s) 0.89 (3H, s)
3-O-b-D-Glucopyranosyl 6-O-b-D-Glucopyranosyl 6-O-b-D-Glucopyranosyl 6-O-b-D-Glucopyranosyl 28-O-b-D-Glucopyranosyl
10 4.89 (1H, m) 4.98 (1H, m) 5.01 (1H, d, J ¼ 7.8) 4.91 (1H, d, J ¼ 7.5) 6.31 (1H, d, J ¼ 8.1)
20 4.20 (1H, m) 4.04 (1H, m) 4.06 (1H, m) 4.22 (1H, m) 4.18 (1H, m)
30 4.21 (1H, m) 4.20 (1H, m) 4.23 (1H, m) 4.23 (1H, m) 4.01 (1H, m)
40 4.11 (1H, m) 4.16 (1H, m) 4.19 (1H, m) 4.13 (1H, m) 4.33 (1H, m)
50 3.89 (1H, m) 3.91 (1H, m) 3.92 (1H, m) 3.90 (1H, m) 4.26 (1H, m)
60a 4.53 (1H, m) 4.48 (1H, dd, J ¼ 2.6, 11.6) 4.51 (1H, dd, J ¼ 11.5, 2.5) 4.55 (1H, dd, J ¼ 2.0, 11.7) 4.45 (1H, m)
60b 4.32 (1H, m) 4.32 (1H, dd, J ¼ 5.4, 11.6) 4.33 (1H, dd, J ¼ 11.5, 5.4) 4.32 (1H, m) 4.37 (1H, m)
20-O-b-D-Glucopyranosyl 20-O-b-D-Glucopyranosyl
10 0 5.33 (1H, d, J ¼ 7.6) 5.35 (1H, d, J ¼ 7.6)
20 0 4.09 (1H, m) 4.12 (1H, m)
30 0 4.28 (1H, m) 4.32 (1H, m)
40 0 4.28 (1H, m) 4.30 (1H, m)
50 0 3.89 (1H, m) 3.90 (1H, m)
60 0a 4.47 (1H, m) 4.46 (2H, m)
60 0b 4.43 (1H, m)
1H-NMR data measured at 500 MHz
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Table 6
13C-NMR Spectroscopic Data for Compounds 17e21 in Pyridine-d5
No. Rk1 (17) Rh4 (18) 25-hydroxy-Rh4 (19) Rg5 (20) Oleanolic acid 28-O-b-D-glucopyranoside (21)
dC multiplicity
1 39.3 t 39.4 t 39.5 t 39.3 t 39.0 t
2 26.7 t 28.7 t 27.9 t 26.7 t 28.1 t
3 88.9 d 78.5 d 78.5 d 88.9 d 78.1 d
4 39.7 s 40.3 s 40.3 s 40.2 s 39.4 s
5 56.4 d 61.4 d 61.4 d 56.4 d 55.8 d
6 18.4 t 80.0 d 80.0 d 18.4 t 18.8 t
7 35.3 t 45.2 t 45.3 t 35.3 t 33.1 t
8 40.2 s 41.3 s 41.3 s 39.7 s 40.0 s
9 48.2 d 50.5 d 50.5 d 50.8 d 48.1 d
10 37.0 s 39.7 s 39.7 s 37.0 s 37.4 s
11 32.6 t 32.2 t 32.2 t 32.2 t 23.4 t
12 72.4 d 72.5 d 72.6 d 72.6 d 122.9 d
13 52.4 d 50.3 d 50.8 d 50.4 d 144.1 s
14 51.2 s 50.6 s 50.6 s 50.9 s 42.1 s
15 32.6 t 32.5 t 32.5 t 32.6 t 28.3 t
16 30.7 t 27.8 t 28.7 t 28.1 t 23.6 t
17 50.8 d 50.7 d 50.5 d 51.0 d 47.0 s
18 15.8 q 17.3 q 16.8 q 15.8 q 41.8 d
19 16.4 q 17.6 q 17.7 q 16.6 q 46.2 t
20 155.5 s 140.0 s 139.5 s 140.2 s 30.8 s
21 108.1 t 13.0 q 13.0 q 13.1 q 34.0 t
22 33.8 t 123.5 d 125.5 d 123.2 d 32.5 t
23 27.0 t 27.4 t 23.6 t 27.4 t 28.8 q
24 125.3 d 123.8 d 44.2 t 123.5 d 16.5 q
25 131.2 s 131.2 s 69.5 s 131.2 s 15.6 q
26 25.7 q 25.6 q 29.9 q 25.7 q 17.5 q
27 17.7 q 17.6 q 29.7 q 17.7 q 26.1 q
28 28.1 q 31.6 q 31.7 q 28.8 q 176.4 s
29 16.5 q 16.3 q 16.3 q 16.4 q 33.2 q
30 17.0 q 16.7 q 17.4 q 17.0 q 23.8 q
3-O-b-D-Glucopyranosyl 6-O-b-D-Glucopyranosyl 6-O-b-D-Glucopyranosyl 6-O-b-D-Glucopyranosyl 28-O-b-D-Glucopyranosyl
10 105.1 d 105.9 d 106.0 d 105.1 d 95.7 d
20 83.4 d 75.3 d 75.4 d 83.4 d 74.1 d
30 77.9 d 79.5 d 79.6 d 78.2 d 79.3 d
40 71.6 d 71.7 d 71.8 d 71.6 d 71.1 d
50 78.2 d 78.0 d 78.1 d 77.9 d 78.9 d
60 62.8 t 63.0 t 63.1 t 62.7 t 62.2 t
20-O-b-D-Glucopyranosyl 20-O-b-D-Glucopyranosyl
10 0 106.0 d 106.0 d
20 0 77.0 d 77.1 d
30 0 78.3 d 78.3 d
40 0 71.6 d 71.7 d
50 0 78.0 d 78.1 d
60 0 62.7 t 62.8 t
Multiplicity of 13C NMR data was determined by DEPT experiments
13C-NMR data measured at 125 MHz
H. Yang et al / Ginsenoside 1H-NMR and 13C-NMR data 201Compounds 5 and 6, and 13 and 14were isolated as mixtures of the
stereoisomers and were not puriﬁed to individual stereoisomers.
Compounds 1e21 were categorized by their backbones (PPD type
1e6; PPD-derived type, 7, 8, 18, and 19; PPT type, 9e12, 15, and 16;
PPT-derived type, 13, 14, and 17; and an oleanane-type triterpene,
21). The 1H-NMR and 13C-NMR spectral data are given in Tables 1e
6.
The comprehensive 1H-NMR and 13C-NMR spectral data of
compounds 1e21 are worth determining for the structures of the
less polar ginsenosides as some of their 1H-NMR and 13C-NMR
spectroscopic data are not available. Other data are either scattered
throughout published papers, or dated, therefore it is hard to
compare the structures of the isolated compounds. In the study, the
results were assigned using one-dimensional and two-dimensional
NMR spectroscopic methods and were also conﬁrmed by compar-
isonwith previously published data. Some signals, such as those for
the methyl groups of C-26eC-30 and the saturated methylenes,
which have not been reported previously, were unambiguously
determined using two-dimensional NMR spectra including 1H-1H
COSY, HSQC and HMBC spectra.The 13C-NMR spectral data suggested the following information
for the structural elucidation of the ginsenosides isomers. First, the
chemical shifts of the characteristic peaks between the 20(S) and
20(R) ginsenosides provided information for the identiﬁcation of
the stereoisomers. In particular, changes in the chemical shifts
between the S- and R- forms at C-17, C-21 and C-22 in the 13C-NMR
spectra were approximately Dd (dS e dR) þ4.1  0.1, þ4.3  0.1,
and 7.4  0.1 ppm, respectively (Tables 2 and 4). Next, the pres-
ence of the signal (dC 88.8 0.1 ppm) of the hydroxyl carbon at C-3,
which did not overlap with other hydroxyl groups in the backbone
and the sugarmoieties, easily indicatedwhether it was a PPD- (1e8,
17, and 20) or PPT-type (9e16 and 18). In addition, the signals at dC
170.6  0.1 showed the existence of the acetyl groups (5, 6, 15, and
16) (Tables 2 and 4). It was assumed that they were produced from
the malonyl moiety by decarboxylation during the manufacturing
process and were located at C-6 in the glucose group (5, 6, 15, and
16) [23]. Finally, the chemical shifts of the down-ﬁeld signals
indicated the type of backbones. The values for a double bond at
D24(25) in 3,12,20-trihydroxydammar-24-ene and 3,6,12,20-tetra-
hydroxydammar-24-ene (1e6, 9e12,15, and 16) were dC 126.10.2
J Ginseng Res 2014;38:194e202202(C-24) and 130.1  0.1 (C-25), respectively (Tables 2 and 4). How-
ever, theywere shifted to dC 124.21.0 and 131.2 0.0 as a result of
the dehydration at D20(21) (17) or D20(22) (18 and 20) (Table 6).
The differences between the chemical shifts of dC 155.5 and 108.1,
and of dC 140.1  0.1 and 123.4  0.2 ppm indicated the discrimi-
nation of 3,12-dihydroxydammar-20, 24-diene (17) and 3,12-dihy-
droxydammar-20(22),24-diene (18 and 20). These results were in
perfect agreement with previously published values [21,24,25].
Compound 21, an oleanane-type triterpene, might be produced by
the selective hydrolysis of sugar residues at C-3 in ginsenoside Ro
[26] (Table 6).
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